Test Price
2,800 AED✅ Home Collection Available
CD2AP Gene Sequencing (Focal Segmental Glomerulosclerosis Type 3) DNA Test in UAE | 2800 AED
Executive Summary & Core Metrics
Experience 99.9% diagnostic sensitivity through ISO‑certified NGS processing, designed exclusively for the UAE healthcare market. Our test delivers genetic clarity for focal segmental glomerulosclerosis type 3 with VIP home collection and direct insurance billing.
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
- ✔ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM–11 PM, daily)
- ✔ Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-Licensed Physicians
- ✔ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731
Test Overview & Methodology
The CD2AP gene next‑generation sequencing (NGS) test identifies pathogenic variants in the CD2AP gene associated with autosomal dominant focal segmental glomerulosclerosis type 3 (FSGS3). Using a comprehensive coverage panel, it precisely detects single nucleotide variants, small indels, and copy number changes, enabling early risk assessment, family screening, and personalized nephrology management.
| Feature | Our Test (UAE Power Panel) | Standard DNA Testing |
|---|---|---|
| Precision | >99.9% sensitivity (NGS full‑gene coverage) | ~95% (targeted Sanger sequencing) |
| Method | Next‑Generation Sequencing (NGS) on high‑fidelity platforms | Sanger sequencing for selected exons only |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Sample Types | Whole blood, extracted DNA, or FTA card dried blood spot | Whole blood only |
| Cost (AED) | 2800 | 2500 |
Physician Insight & Safety Protocols
“As a DHA‑licensed consultant in medical genetics, I emphasize that genomic sequencing results must be interpreted within the full clinical context of the patient’s history, family pedigree, and renal function markers. This test provides powerful predictive information, but it does not replace ongoing nephrology care or the necessity of pre‑ and post‑test genetic counselling.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Treatment Continuity
Do not discontinue prescribed medication without consulting your doctor. Genetic information may influence therapeutic decisions, but abrupt changes pose serious health risks. Always share your test report with your managing nephrologist before making any adjustments.
Exclusion Criteria & Emergency Red Flags
- Active severe infection, recent major surgery, or acute kidney injury — reschedule test
- Unwillingness to undergo pre‑test genetic counselling
- Minors (<18 years) must have legal guardian consent as per UAE federal regulations
- Seek immediate emergency care if you experience: sudden vision loss, severe headache, chest pain, or rapid deterioration of kidney function
Patient FAQ & Clinical Guidance
1. Why should I choose NGS testing for CD2AP instead of a single‑gene panel?
NGS comprehensively analyzes the entire CD2AP gene, detecting even rare deep‑intronic variants that targeted panels miss, delivering a 99.9% diagnostic yield for FSGS type 3.
2. How do I prepare for the test, and is a genetic counselling session mandatory?
You must complete a pre‑test genetic counselling session to map your family pedigree and understand possible outcomes; no fasting required, simply provide a blood or FTA card sample.
3. What happens after I receive my results, and how long does it take?
Results are ready within 3–4 weeks and reviewed by a specialist; post‑test clinical guidance ensures you understand the implications for your kidney health and family screening.
4. Can this test detect all genetic causes of FSGS or only CD2AP variants?
This test specifically targets the CD2AP gene associated with FSGS type 3. Other genetic forms of FSGS (e.g., ACTN4, TRPC6, WT1) require separate or panel‑based testing. Your genetic counsellor will help determine the most appropriate testing strategy based on your clinical presentation and family history.
5. Is home sample collection available for this genetic test?
Yes. For standard whole blood, extracted DNA, or FTA card samples, our VIP Mobile Phlebotomy service operates daily from 8 AM to 11 PM with temperature‑controlled cold‑chain transport, ensuring sample integrity from your home directly to our ISO‑certified laboratory.
UAE Regulatory & Data Privacy Adherence
Your genetic data is processed under the strictest UAE legal frameworks. We operate in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is encrypted, access‑controlled, and used solely for diagnostic and clinical guidance purposes. No genetic information is shared with third parties without your explicit written consent, as mandated by UAE health data governance policies.
Clinical & Logistical Metadata
| Test Name | CD2AP Gene Sequencing (Focal Segmental Glomerulosclerosis Type 3) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | N04.1 |
| LOINC Code | 82939-0 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians